Advertisement
Screener

Nicholas Investment Partners, LP Historic Quarter Change: USA Bonds: Convertible Notes, Sold Out

Nicholas Investment Partners, LP historic quarter change: USA Bonds: Convertible Notes, Sold out

In convertible notes that pay a coupon (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, Nicholas Investment Partners, LP opened 186 positions, added to 168, reduced 221 and sold out of 184.

  • Q2 2026: Stock ASCENDIS PHARMA A/S; Country of operation —; Class NOTE 2.250% 4/0; Principal before $6,035,000.
  • Q2 2026: Stock AMERICAN WTR CAP CORP; Country of operation United States; Class NOTE 3.625% 6/1; Principal before $3,000,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1389574), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-12); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-08); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-14); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-17); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-17); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-05); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-01); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-08); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-13); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2006-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q2 2026ASCENDIS PHARMA A/S
CUSIP 04351PAD3
NOTE 2.250% 4/0$6,035,000$0-6,035,000$8,853,345$0-$8,853,3452026-08-14
Q2 2026AMERICAN WTR CAP CORP
CUSIP 03040WBE4
United StatesNOTE 3.625% 6/1$3,000,000$0-3,000,000$2,993,400$0-$2,993,4002026-08-14

Similar Firms

Firm NameCountry13F ValueHoldings
Fairmount Funds Management LLCUnited States$1.384B12
1607 Capital Partners, LLCUnited States$1.388B139
Opti Capital Management, LPUnited States$1.388B36
Owl Creek Asset Management, L.P.United States$1.383B30
Trivest Advisors LtdHong Kong$1.388B29
ALGEBRIS (UK) LTDUnited Kingdom$1.382B70
Ranger Investment Management, L.P.United States$1.382B79
Blue Chip Partners, LLCUnited States$1.389B170
Sagefield Capital LPUnited States$1.389B219
Advisor OS, LLCUnited States$1.381B2,365